Synta Pharmaceuticals Corp.
NASDAQ: SNTA
$0.34
Closing price July 22, 2016
These biotech stocks 24/7 Wall St. has picked stood out from the rest with at least 25% gains over the course of the past week.
Published:
This past week marked the fifth anniversary of the bottom of the market from March 2009. To celebrate those massive gains since then, the Dow Jones Industrial Average has now fallen five consecutive...
Published:
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday, March 12, 2014. They include AIG, General Motors, Rite Aid, Synta Pharmaceuticals and...
Published:
The biotech market has been on fire this year, and there is every indication that things will continue. With huge binary events right around the corner, and many of the top companies with clinical...
Published:
Here are the top biotech stocks to buy that are trading near the $5 dollar level. We have updated coverage on stocks we have reported on before, and added some top new names to the list.
Published:
Every quarter we like to review the research at the top firms we cover and look for any new stocks to buy that are priced either slightly above or under $5 per share. In the past, many firms were...
Published:
24/7 Wall St. ran a screen of the Wall Street firms we cover looking for biotech stocks trading under $10 that had big upside potential for 2014. These are potentially the next great growth engines...
Published:
The world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not change all that much, the manner in which it can be treated does. That creates...
Published:
Once again, the Wall Street conference calendar is heating up. Next week is the widely attended Jefferies Global Healthcare Conference in New York City. Following the success of last year’s...
Published:
As the stock market keeps rising, investors have to expect that the wave of companies raising cash and insiders selling shares will only continue. We tracked a whopping 10 offerings yesterday alone...
Published:
Last Updated:
The stock market is up Friday on plans for the European Union plans to directly lend to targeted banks. The Dow Jones Industrial Average is up 1.66%, the S&P 500 is up 1.80% and the Nasdaq...
Published:
Last Updated:
How many big movers can you see in one day in the biotech sector? This is what investors should be asking. If you didn’t know better you might think there was a collusion in the biotech...
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Tuesday. ABIOMED Inc. (NASDAQ: ABMD) Cut to Neutral at Lazard Capital. ArcelorMittal...
Published:
Last Updated:
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set to take...
Published:
Last Updated:
We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend.  This is broken down...
Published: